Madeira Therapeutics
Leawood
About Madeira Therapeutics
We are a drug development company specializing in real pediatric medicine by reformulating compounds currently approved for adults with substantial safety and efficacy and determining an accurate pediatric dosage. Currently, 70% of the drugs prescribed for children are not approved by the FDA. Children metabolize drugs more rapidly than adults; our goal is to eliminate the "dosing down" of adult drugs for children based on weight. Madeira Therapeutics is one of the few drug development companies with a dedicated focus on this niche market-formulations that are sized to fit.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $420.0K
- Last round: Series Unknown (Apr 2011)
- Website: madeiratherapeutics.com
- Phone: 913-661-1962
Industries & Categories
Biotechnology, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/madeira-therapeutics-2744225 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.